173 related articles for article (PubMed ID: 35320351)
1. The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling.
Jdeed S; Erdős E; Bálint BL; Uray IP
Mol Cancer Res; 2022 Jul; 20(7):1071-1082. PubMed ID: 35320351
[TBL] [Abstract][Full Text] [Related]
2. Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-β Signaling.
Jdeed S; Lengyel M; Uray IP
Cells; 2022 Aug; 11(17):. PubMed ID: 36078038
[TBL] [Abstract][Full Text] [Related]
3. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
[TBL] [Abstract][Full Text] [Related]
4. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
6. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
7. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors.
Amin S; Kumar A; Nilchi L; Wright K; Kozlowski M
Mol Cancer Res; 2011 Aug; 9(8):1112-25. PubMed ID: 21719561
[TBL] [Abstract][Full Text] [Related]
10. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.
Kang HJ; Yi YW; Kim HJ; Hong YB; Seong YS; Bae I
Cell Death Dis; 2012 Jun; 3(6):e336. PubMed ID: 22739988
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cells.
Morimoto-Kamata R; Yui S
Cancer Sci; 2017 Aug; 108(8):1574-1583. PubMed ID: 28544544
[TBL] [Abstract][Full Text] [Related]
14. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
15. IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Kruger DT; Alexi X; Opdam M; Schuurman K; Voorwerk L; Sanders J; van der Noort V; Boven E; Zwart W; Linn SC
Int J Cancer; 2020 Apr; 146(8):2348-2359. PubMed ID: 31490549
[TBL] [Abstract][Full Text] [Related]
16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
17. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.
Lorenzatti G; Huang W; Pal A; Cabanillas AM; Kleer CG
J Cell Sci; 2011 May; 124(Pt 10):1752-8. PubMed ID: 21525039
[TBL] [Abstract][Full Text] [Related]
18. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
[TBL] [Abstract][Full Text] [Related]
19. Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer.
Fu P; Du F; Liu Y; Hong Y; Yao M; Zheng S
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):123-7. PubMed ID: 26638893
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]